Dow Up0.15% Nasdaq Down0.44%

More On CRTX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Cornerstone Therapeutics Inc. (CRTX)

-NasdaqCM
9.49 Up 0.01(0.11%) Feb 3 - Nasdaq Real Time Price
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Dec 13
Next Qtr.
Mar 14
Current Year
Dec 13
Next Year
Dec 14
Avg. EstimateN/AN/AN/AN/A
No. of AnalystsN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago EPS-0.260.09N/AN/A
Revenue EstCurrent Qtr.
Dec 13
Next Qtr.
Mar 14
Current Year
Dec 13
Next Year
Dec 14
Avg. Estimate41.32MNaN161.70M175.56M
No. of Analysts111
Low Estimate41.32MNaN161.70M175.56M
High Estimate41.32MNaN161.70M175.56M
Year Ago Sales34.93MNaN116.08M161.70M
Sales Growth (year/est)18.30%N/A39.30%8.60%
Earnings HistoryDec 12Mar 13Jun 13Sep 13
EPS Est0.100.130.120.27
EPS Actual-0.260.090.190.31
Difference-0.36-0.040.070.04
Surprise %-360.00%-30.80%58.30%14.80%
EPS TrendsCurrent Qtr.
Dec 13
Next Qtr.
Mar 14
Current Year
Dec 13
Next Year
Dec 14
Current EstimateN/AN/AN/AN/A
7 Days Ago0.29N/A0.830.60
30 Days Ago0.29N/A0.830.60
60 Days Ago0.29N/A0.830.60
90 Days Ago0.29N/A0.830.60
EPS RevisionsCurrent Qtr.
Dec 13
Next Qtr.
Mar 14
Current Year
Dec 13
Next Year
Dec 14
Up Last 7 Days0N/A00
Up Last 30 Days0N/A00
Down Last 30 Days0N/A00
Down Last 90 DaysN/AN/AN/AN/A
Growth EstCRTXIndustrySectorS&P 500
Current Qtr.N/AN/A-75.20%13.60%
Next Qtr.N/AN/A-64.20%23.80%
This YearN/AN/A45.20%7.70%
Next YearN/AN/A34.90%13.00%
Past 5 Years (per annum)-15.54%N/AN/AN/A
Next 5 Years (per annum)N/A21.77%16.14%10.16%
Price/Earnings (avg. for comparison categories)N/A2.636.015.74
PEG Ratio (avg. for comparison categories)N/A29.648.510.85
Currency in USD.